Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,494 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,594 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00036517 | Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer | terminated | Phase 1 / Phase 2 | 30 | PhytoCeuticaINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00043459 | Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma. | terminated | Phase 2 | 35 | TularikINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00057382 |
| T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients |
| terminated |
| Phase 2 / Phase 3 |
| 750 |
| TularikINDUSTRY |
| 11 |
| Jun 24, 2005 |
| clinicaltrials |
| NCT00064636 | Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | terminated | Phase 1 | 46 | Millennium Pharmaceuticals, Inc.INDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Jun 24, 2005source: clinicaltrials